Significance of high levels of endogenous melatonin in mammalian cerebrospinal fluid and in the central nervous system

Current Neuropharmacology

Volumn 8, Issue 3, 2010, Pages 162-167

  Tan, Dun Xian ^a   Manchester, Lucien C ^a   Sanchez Barcelo, Emilio ^a   Mediavilla, Maria D ^a   Reiter, Russel J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

CNS; CSF; Melatonin; Neurodegenerative disease; Oxidative stress; Pineal gland

Indexed keywords

MELATONIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; BODY FLUID; BRAIN THIRD VENTRICLE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL FEATURE; CLINICAL STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; GLIA CELL; HUMAN; MAMMAL; NERVE CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL CIRCULATION; PINEAL BODY;

EID: 78549295540     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015910792246182     Document Type: Article

References (72)

1. Acuna-Castroviejo, D., Escames, G., Lopez, L. C., Hitos, A. B., Leon, J. Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis. Endocrine, 2005, 27, 159-168.
2. Arnao, M. B., Hernandez-Ruiz, J. Chemical stress by different agents affects the melatonin content of barley roots. J. Pineal Res., 2009, 46, 295-299.
3. Asayama, K., Yamadera, H., Ito, T., Suzuki, H., Kudo, Y., Endo, S. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J. Nippon Med. Sch., 2003, 70, 334-341.
4. Bongiorno, D., Ceraulo, L., Ferrugia, M., Filizzola, F., Ruggirello, A., Liveri, V. T. Localization and interactions of melatonin in drycholesterol/lecithin mixed reversed micelles used as cell membranemodels. J. Pineal Res., 2005, 38, 292-298.
5. Borlongan, C. V., Sumaya, I., Moss, D., Kumazaki, M., Sakurai, T., Hida, H., Nishino, H. Melatonin-secreting pineal gland: a novel tissue source for neural transplantation therapy in stroke. Cell Trans-plant., 2003, 12, 225-234.
6. Brusco, L. I., Fainstein, I., Marquez, M., Cardinali, D. P. Effect of melatonin in selected populations of sleep-disturbed patients. Biol. Signals Recept., 1999, 8, 126-131.
7. Brusco, L. I., Marquez, M., Cardinali, D. P. Monozygotic twins with Alzheimer's disease treated with melatonin: Case report. J. PinealRes., 1998, 25, 260-263.
8. Brzezinski, A., Seibel, M. M., Lynch, H. J., Deng, M. H., Wurtman, R. J. Melatonin in human preovulatory follicular fluid. J. Clin. Endocrinol. Metab., 1987, 64, 865-867.
9. Caballero, B., Vega-Naredo, I., Sierra, V., Huidobro-Fernandez, C., Soria-Valles, C., De Gonzalo-Calvo, D., Tolivia, D., Pallas, M., Camins, A., Rodriguez-Colunga, M. J., Coto-Montes, A. Melatoninalters cell death processes in response to age-related oxidative stress in the brain of senescence-accelerated mice. J. Pineal Res., 2009, 46, 106-114.
10. Cardinali, D. P. Molecular mechanisms of neuroendocrine integration in the central nervous system: an approach through the study of the pineal gland and its innervating sympathetic pathway. Psychoneuroendocrinology, 1983, 8, 3-30.
11. Carloni, S., Perrone, S., Buonocore, G., Longini, M., Proietti, F., Balduini, W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J. Pineal Res., 2008, 44, 157-164.
12. Carretero, M., Escames, G., Lopez, L. C., Venegas, C., Dayoub, J. C., Garcia, L., Acuna-Castroviejo, D. Long-term melatonin ad-ministration protects brain mitochondria from aging. J. Pineal Res. 2009, 47(2), 192-200.
13. Ceinos, R. M., Chansard, M., Revel, F., Calgari, C., Miguez, J. M., Simonneaux, V. Analysis of adrenergic regulation of melatonin synthesis in Siberian hamster pineal emphasizes the role of HIOMT. Neurosignals, 2004, 13, 308-317.
14. Cervantes, M., Morali, G., Letechipia-Vallejo, G. Melatonin and ischemia-reperfusion injury of the brain. J. Pineal Res., 2008, 45, 1-7.
15. Cheng, Y., Feng, Z., Zhang, Q. Z., Zhang, J. T. Beneficial effects of melatonin in experimental models of Alzheimer disease. ActaPharmacol. Sin., 2006, 27, 129-139.
16. Cohen-Mansfield, J., Garfinkel, D., Lipson, S. Melatonin for treatment of sun downing in elderly persons with dementia - a preliminary study. Arch. Gerontol. Geriatr., 2000, 31, 65-76.
17. De Pedro, N., Martinez-Alvarez, R. M., Delgado, M. J. Melatoninreduces body weight in goldfish (Carassius auratus): effects on metabolic resources and some feeding regulators. J. Pineal Res., 2008, 45, 32-39.
18. Debus, O. M., Lerchl, A., Bothe, H. W., Bremer, J., Fiedler, B., Franssen, M., Koehring, J., Steils, M., Kurlemann, G. Spontaneous central melatonin secretion and resorption kinetics of exogenous melatonin: aventricular CSF study. J. Pineal Res., 2002, 33, 213-217.
19. Dubocovich, M. L. Pharmacology and function of melatonin receptors. FASEB J., 1988, 2, 2765-2773.
20. Erren, T. C., Reiter, R. J. Defining chronodisruption. J. Pineal Res., 2009, 46, 245-247.
21. Hardeland, R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine, 2005, 27, 119-130.
22. Hattori, A., Migitaka, H., Iigo, M., Itoh, M., Yamamoto, K., Ohtani-Kaneko, R., Hara, M., Suzuki, T., Reiter, R. J. Identificationof melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int., 1995, 35, 627-634.
23. Hirata, F., Hayaishi, O., Tokuyama, T., Seno, S. In vitro and in vivo formation of two new metabolites of melatonin. J. Biol. Chem., 1974, 249, 1311-1313.
24. Huether, G. The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia, 1993, 49, 665-670.
25. Iriti, M. Melatonin in grape, not just a myth, maybe a panacea. J. Pineal Res., 2009, 46, 353.
26. Iriti, M., Faoro, F. Bioactivity of grape chemicals for human health. Nat. Prod. Commun., 2009, 4, 611-634.
27. Jan, J. E., Reiter, R. J., Wasdell, M. B., Bax, M. The role of the thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J. Pineal Res., 2009, 46, 1-7.
28. Jaworek, J., Leja-Szpak, A., Bonior, J., Nawrot, K., Tomaszewska, R., Stachura, J., Sendur, R., Pawlik, W., Brzozowski, T., Konturek, S. J. Protective effect of melatonin and its precursor L-tryptophanon acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion. J. Pineal Res., 2003, 34, 40-52.
29. Lerner, A. B., Case, J. D., Takahashi, Y. Isolation of melatonin and5-methoxyindole-3-acetic acid from bovine pineal glands. J. Biol. Chem., 1960, 235, 1992-1997.
30. Leston, J., Harthe, C., Brun, J., Mottolese, C., Mertens, P., Sindou, M., Claustrat, B. Melatonin is released in the third ventricle inhumans. A study in movement disorders. Neurosci. Lett., 2010, 469, 294-297.
31. Liu, R. Y., Zhou, J. N., van Heerikhuize, J., Hofman, M. A., Swaab, D. F. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J. Clin. Endocrinol. Metab., 1999, 84, 323-327.
32. Liu, T., Borjigin, J. N-acetyltransferase is not the rate-limitingenzyme of melatonin synthesis at night. J. Pineal Res., 2005, 39, 91-96.
33. Liu, Y. J., Zhuang, J., Zhu, H. Y., Shen, Y. X., Tan, Z. L., Zhou, J. N. Cultured rat cortical astrocytes synthesize melatonin: absence of adiurnal rhythm. J. Pineal Res., 2007, 43, 232-238.
34. Longatti, P., Perin, A., Rizzo, V., Comai, S., Bertazzo, A., Allegri, G. Endoscopic selective sampling of human ventricular CSF: a newperspective. Minim. Invas. Neurosurg., 2004, 47, 350-354.
35. Longatti, P., Perin, A., Rizzo, V., Comai, S., Giusti, P., Costa, C. V. Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique. J. Pineal Res., 2007, 42, 113-118.
36. Mahlberg, R., Kunz, D., Sutej, I., Kuhl, K. P., Hellweg, R. Melatonin treatment of day-night rhythm disturbances and sun downing in Alzheimer disease: an open-label pilot study using actigraphy. J. Clin. Psychopharmacol., 2004, 24, 456-459.
37. Maldonado, M. D., Moreno, H., Calvo, J. R. Melatonin present inbeer contributes to increase the levels of melatonin and antioxidant capacity of the human serum. Clin. Nutr., 2009, 28, 188-191.
38. Manchester, L. C., Tan, D. X., Reiter, R. J., Park, W., Monis, K., Qi, W. High levels of melatonin in the seeds of edible plants: possible function in germ tissue protection. Life Sci., 2000, 67, 3023-3029.
39. Manda, K., Ueno, M., Anzai, K. Cranial irradiation-induced inhibition of neurogenesis in hippocampal dentate gyrus of adult mice: attenuation by melatonin pretreatment. J. Pineal Res, 2009, 46, 71-78.
40. Matsubara, E., Bryant-Thomas, T., Pacheco Quinto, J., Henry, T. L., Poeggeler, B., Herbert, D., Cruz-Sanchez, F., Chyan, Y. J., Smith, M. A., Perry, G., Shoji, M., Abe, K., Leone, A., Grundke-Ikbal, I., Wilson, G. L., Ghiso, J., Williams, C., Refolo, L. M., Pappolla, M. A., Chain, D. G., Neria, E. Melatonin increases survivaland inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J. Neurochem., 2003, 85, 1101-1108.
41. Maurizi, C. P. Choroid plexus portals and a deficiency of melatonin can explain the neuropathology of Alzheimer's disease. Med. Hypotheses., 2010, 74, 1059-1066.
42. Mitchell, M. D., Sayers, L., Keirse, M. J., Anderson, A. B., Turnbull, A. C. Melatonin in amniotic fluid during human parturition. Br. J. Obstet. Gynaecol., 1978, 85, 684-686.
43. Nunomura, A., Moreira, P. I., Lee, H. G., Zhu, X., Castellani, R. J., Smith, M. A., Perry, G. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol. Disord. Drug Targets, 2007, 6, 411-423.
44. Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., Wang, L., Zhang, C., Lin, X., Zhang, G., Arendash, G. W. Protection against cognitive deficits and markers of neurode-generation by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J. Pineal Res., 2009, 47, 82-96.
45. Paredes, S. D., Korkmaz, A., Manchester, L. C., Tan, D. X., Reiter, R. J. Phytomelatonin: a review. J. Exp. Bot., 2009, 60, 57-69.
46. Pelham, R. W. A serum melatonin rhythm in chickens and its abolition by pinealectomy. Endocrinology, 1975, 96, 543-546.
47. Rao, K. S. Free radical induced oxidative damage to DNA: relationto brain aging and neurological disorders. Indian J. Biochem. Biophys., 2009, 46, 9-15.
48. Reiter, R. J. Pineal melatonin: cell biology of its synthesis and of itsphysiological interactions. Endocr. Rev., 1991, 12, 151-180.
49. Reiter, R. J., Paredes, S. D., Korkmaz, A., Manchester, L. C., Tan, D. X. Melatonin in relation to the strong and weak versions of the free radical theory of aging. Adv. Med. Sci., 2008, 53, 119-129.
50. Reiter, R. J., Paredes, S. D., Manchester, L. C., Tan, D. X. Reducingoxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit. Rev. Biochem. Mol. Biol., 2009, 44, 175-200.
51. Reiter, R. J., Tan, D. X., Manchester, L. C., Tamura, H. Melatonindefeats neurally-derived free radicals and reduces the associatedneuromorphological and neurobehavioral damage. J. Physiol. Pharmacol., 2007, 58(Suppl 6), 5-22.
52. Ribelayga, C., Pevet, P., Simonneaux, V. HIOMT drives the photoperiodic changes in the amplitude of the melatonin peak of the Siberian hamster. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2000, 278, R1339-1345.
53. Rizzo, V., Porta, C., Moroni, M., Scoglio, E., Moratti, R. Determination of free and total (free plus protein-bound) melatonin inplasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 2002, 774, 17-24.
54. Rousseau, A., Petren, S., Plannthin, J., Eklundh, T., Nordin, C. Serum and cerebrospinal fluid concentrations of melatonin: a pilotstudy in healthy male volunteers. J. Neural. Transm., 1999, 106, 883-888.
55. Seifman, M. A., Adamides, A. A., Nguyen, P. N., Vallance, S. A., Cooper, D. J., Kossmann, T., Rosenfeld, J. V., Morganti-Kossmann, M. C. Endogenous melatonin increases in cerebrospinal fluid of patients after severe traumatic brain injury and correlates with oxidative stress and metabolic disarray. J. Cereb. Blood Flow Metab., 2008, 28, 684-696.
56. Sheridan, M. N., Reiter, R. J. Observations on the pineal system in the hamster. II. Fine structure of the deep pineal. J. Morphol., 1970, 31, 163-177.
57. Sheridan, M. N., Reiter, R. J., Jacobs, J. J. An interesting anatomical relationship between the hamster pineal gland and the ventricular system of the brain. J. Endocrinol., 1969, 45, 131-132.
58. Shieh, J. M., Wu, H. T., Cheng, K. C., Cheng, J. T. Melatonin ameliorates high fat diet-induced diabetes and stimulates glycogen synthesis via a PKCzeta-Akt-GSK3beta pathway in hepatic cells. J. Pineal Res., 2009, 47, 339-344.
59. Silva, S. O., Ximenes, V. F., Livramento, J. A., Catalani, L. H., Campa, A. High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J. Pineal Res., 2005, 39, 302-306.
60. Simko, F., Pechanova, O. Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. J. PinealRes., 2009, 47, 127-133.
61. Skene, D. J., Vivien-Roels, B., Sparks, D. L., Hunsaker, J. C., Pevet, P., Ravid, D., Swaab, D. F. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res., 1990, 528, 170-174.
62. Skinner, D. C., Malpaux, B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology, 1999, 140, 4399-4405.
63. Stefulj, J., Hortner, M., Ghosh, M., Schauenstein, K., Rinner, I., Wolfler, A., Semmler, J., Liebmann, P. M. Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of therat. J. Pineal Res., 2001, 30, 243-247.
64. Tajes, M., Gutierrez-Cuesta, J., Ortuno-Sahagun, D., Camins, A., Pallas, M. Anti-aging properties of melatonin in an in vitro murine senescence model: involvement of the sirtuin 1 pathway. J. PinealRes., 2009, 47, 228-237.
65. Tan, D., Manchester, L. C., Reiter, R. J., Qi, W., Hanes, M. A., Farley, N. J. High physiological levels of melatonin in the bile of mammals. Life Sci., 1999, 65, 2523-2529.
66. Tan, D. X., Chen, L. D., Poeggeler, B., Manchester, L., Reiter, R. J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J., 1993, 1, 57-60.
67. Tan, D. X., Hardeland, R., Manchester, L. C., Paredes, S. D., Korkmaz, A., Sainz, R. M., Mayo, J. C., Fuentes-Broto, L., Reiter, R. J. The changing biological roles of melatonin during evolution: froman antioxidant to signals of darkness, sexual selection and fitness. Biol. Rev. Camb. Philos. Soc., 2010, 85, 607-623.
68. Tan, D. X., Manchester, L. C., Reiter, R. J., Qi, W. B., Zhang, M., Weintraub, S. T., Cabrera, J., Sainz, R. M., Mayo, J. C. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta, 1999, 1472, 206-214.
69. Tan, D. X., Manchester, L. C., Terron, M. P., Flores, L. J., Reiter, R. J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. PinealRes., 2007, 42, 28-42.
70. Tan, D. X., Reiter, R. J., Manchester, L. C., Yan, M. T., El-Sawi, M., Sainz, R. M., Mayo, J. C., Kohen, R., Allegra, M., Hardeland, R. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem., 2002, 2, 181-197.
71. Tricoire, H., Locatelli, A., Chemineau, P., Malpaux, B. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology, 2002, 143, 84-90.
72. Zhou, J. N., Liu, R. Y., Kamphorst, W., Hofman, M. A., Swaab, D. F. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J. Pineal Res., 2003, 35, 125-130.